(c) 2024 PillSync.com

sevelamer carbonate 800 MG Oral Tablet Renvela

1 INDICATIONS AND USAGE Renvela ® (sevelamer carbonate) is indicated for the control of serum phosphorus in adults and children 6 years of age and older with chronic kidney disease (CKD) on dialysis. Renvela ® is a phosphate binder indicated for the control of serum phosphorus in adults and children 6 years of age and older with chronic kidney disease on dialysis. ( 1 )

Genzyme Corporation


3 years ago OVAL WHITE RENVELA 800 sevelamer carbonate 800 MG Oral Tablet Renvela

OVAL WHITE RENVELA 800

3 years ago OVAL WHITE RENVELA 800 sevelamer carbonate 800 MG Oral Tablet Renvela

RENVELA 800 OVAL WHITE

16 HOW SUPPLIED/STORAGE AND HANDLING Tablets: Renvela ® (

SEVELAMER CARBONATE) tablets, for oral use is supplied as white oval, film-coated, compressed tablets, engraved with RV800 on one side, containing 800 mg of

SEVELAMER CARBONATE on an anhydrous basis. 1 Bottle of 270 ct 800 mg tablets (NDC 58468-0133-1) Powder: Renvela ® (

SEVELAMER CARBONATE) for oral suspension is supplied as opaque, foil-lined, heat-sealed, packets containing 0.8 g or 2.4 g of

SEVELAMER CARBONATE on an anhydrous basis. 1 Box (NDC 58468-0131-2) of 90 ct 2.4 g packets (NDC 58468-0131-1) 1 Box (NDC 58468-0132-2) of 90 ct 0.8 g packets (NDC 58468-0132-1) Storage: Store at 25°C (77°F): excursions permitted to 15°C–30°C (59°F–86°F). [See USP controlled room temperature] Protect from moisture.


More pills like OVAL RENVELA 800

Related Pills












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site